We are live on
!
Find out more
Axa Portfolio holdings
AUM
$91.9M
1-Year Est. Return
27.41%
This Fund
S&P 500
This Quarter
Est. Return
-5.85%
1 Year Est. Return
+27.41%
3 Year Est. Return
+100.68%
5 Year Est. Return
+129.89%
10 Year Est. Return
+554.73%
AUM
$35.2B
AUM Growth
-$3.94B
(-10%)
Cap. Flow
-$1.12B
Cap. Flow
% of AUM
-3.19%
Top 10 Holdings %
Top 10 Hldgs %
20.4%
Holding
1,273
New
111
Increased
414
Reduced
514
Closed
94
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$63.8M |
| 2 |
Align Technology
ALGN
|
+$61.4M |
| 3 |
Stellantis
STLA
|
+$54.4M |
| 4 |
UBS Group
UBS
|
+$49.7M |
| 5 |
Republic Services
RSG
|
+$44M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ferrari
RACE
|
+$73.1M |
| 2 |
IPG Photonics
IPGP
|
+$62.1M |
| 3 |
Adobe
ADBE
|
+$61.1M |
| 4 |
UnitedHealth
UNH
|
+$56.3M |
| 5 |
Apple
AAPL
|
+$54.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.86% |
| 2 | Healthcare | 17.08% |
| 3 | Financials | 11.33% |
| 4 | Consumer Discretionary | 10.87% |
| 5 | Industrials | 8.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PDCO
526
DELISTED
Patterson Companies, Inc.
PDCO
| $7.3M | 0.02% |
225,600
-8,300
| -4% | -$246K |
|
|
MDRX
527
DELISTED
Veradigm Inc. Common Stock
MDRX
| $7.3M | 0.02% |
324,000
-11,800
| -4% | -$239K |
|
528
HF Sinclair
DINO
$20B
| $7.22M | 0.02% |
181,200
+85,100
| +89% | +$2.99M |
|
|
ACH
529
Accendra Health
ACH
$85.4M
| $7.21M | 0.02% |
163,700
+5,800
| +4% | +$249K |
|
530
Essex Property Trust
ESS
$17.7B
| $7.19M | 0.02% |
20,806
+86
| +0.4% | +$28.7K |
|
|
HBI
531
DELISTED
Hanesbrands
HBI
| $7.11M | 0.02% |
477,600
-202,000
| -30% | -$3.18M |
|
532
ABM Industries
ABM
$2.93B
| $7.08M | 0.02% |
153,700
-3,600
| -2% | -$157K |
|
|
ITOS
533
DELISTED
iTeos Therapeutics
ITOS
| $7.05M | 0.02% |
218,973
+2
| +0% | +$73 |
|
534
Genuine Parts
GPC
$18.1B
| $7.02M | 0.02% |
55,689
+53,575
| +2,534% | +$6.93M |
|
|
SWN
535
DELISTED
Southwestern Energy Company
SWN
| $6.96M | 0.02% |
970,600
+25,100
| +3% | +$126K |
|
|
PRFT
536
DELISTED
Perficient Inc
PRFT
| $6.91M | 0.02% |
62,800
-2,400
| -4% | -$252K |
|
537
Phreesia
PHR
$642M
| $6.9M | 0.02% |
261,839
-15,005
| -5% | -$460K |
|
538
Virtu Financial
VIRT
$5.12B
| $6.89M | 0.02% |
185,200
+44,000
| +31% | +$1.45M |
|
539
Shopify
SHOP
$167B
| $6.89M | 0.02% |
101,970
+44,240
| +77% | +$3.63M |
|
540
NetApp
NTAP
$37.3B
| $6.87M | 0.02% |
82,825
-41,674
| -33% | -$3.62M |
|
541
Alkermes
ALKS
$7.72B
| $6.84M | 0.02% |
+260,050
| New | +$6.44M |
|
542
Arcutis Biotherapeutics
ARQT
$2.96B
| $6.84M | 0.02% |
354,943
+58,690
| +20% | +$993K |
|
543
Kinder Morgan
KMI
$68.5B
| $6.82M | 0.02% |
360,812
+8,135
| +2% | +$143K |
|
|
DEA
544
Easterly Government Properties
DEA
$1.12B
| $6.74M | 0.02% |
127,588
| – | – |
|
545
Cushman & Wakefield Ltd
CWK
$2.94B
| $6.71M | 0.02% |
327,000
-14,600
| -4% | -$309K |
|
546
Park Hotels & Resorts
PK
$3.06B
| $6.71M | 0.02% |
343,366
+2,000
| +0.6% | +$37.5K |
|
547
Deutsche Bank
DB
$72.7B
| $6.65M | 0.02% |
525,434
+346,254
| +193% | +$4.6M |
|
|
BHVN
548
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $6.6M | 0.02% |
55,656
-5,391
| -9% | -$672K |
|
549
Lufax Holding
LU
$1.05B
| $6.6M | 0.02% |
296,038
-30,588
| -9% | -$674K |
|
550
Olin
OLN
$1.95B
| $6.55M | 0.02% |
125,200
-15,200
| -11% | -$777K |
|
Similar funds
VI
FA
PBCM
CCAM
GBA
AWP
HI
DCA
Axa's Q1 2022 Portfolio in Review
As of Q1 2022, Axa held 1,273 positions worth $35.2B, down 10% from $39.1B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Axa withdrew a net $1.12B in Q1 2022, closing 94 positions and reducing 514 holdings. Its most notable exit was Zai Lab, an estimated $21.3M position sold in full.
By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 32% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Axa opened a new position in Freshpet worth $30.3M.
- Axa's largest Q1 2022 buy was Freshpet: 294,939 shares worth $30.3M.
- Axa added most to Pfizer in Q1 2022, an estimated $63.8M increase.
- Axa's biggest Q1 2022 reduction was Ferrari, cutting an estimated $73.1M.
- Axa fully exited Zai Lab in Q1 2022, selling an estimated $21.3M.
- Axa's ten largest holdings make up 20% of its $35.2B portfolio in Q1 2022.
- Axa opened 111 new positions and closed 94 in Q1 2022.
- Axa's portfolio value fell 10% quarter-over-quarter to $35.2B.
Based on Axa's 13F filing for Q1 2022, filed 13 May 2022.